| Prevalence of pain in patients with cancer: a systematic review of the past 40 years MHJ Van den Beuken-van Everdingen, JM De Rijke, AG Kessels, ... Annals of oncology 18 (9), 1437-1449, 2007 | 2404 | 2007 |
| High-dose daunorubicin in older patients with acute myeloid leukemia B Löwenberg, GJ Ossenkoppele, W van Putten, HC Schouten, C Graux, ... New England Journal of Medicine 361 (13), 1235-1248, 2009 | 1001 | 2009 |
| Long-term survival and late deaths after allogeneic bone marrow transplantation G Socié, JV Stone, JR Wingard, D Weisdorf, PJ Henslee-Downey, ... New England Journal of Medicine 341 (1), 14-21, 1999 | 805 | 1999 |
| High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin’s lymphoma: results from the randomized European CUP trial HC Schouten, W Qian, S Kvaloy, A Porcellini, H Hagberg, HE Johnsen, ... Journal of clinical oncology 21 (21), 3918-3927, 2003 | 635 | 2003 |
| Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and … JJ Cornelissen, WLJ Van Putten, LF Verdonck, M Theobald, E Jacky, ... Blood 109 (9), 3658-3666, 2007 | 618 | 2007 |
| Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among … RM Emanuel, AC Dueck, HL Geyer, JJ Kiladjian, S Slot, S Zweegman, ... Journal of clinical oncology 30 (33), 4098-4103, 2012 | 520 | 2012 |
| Cytarabine dose for acute myeloid leukemia B Löwenberg, T Pabst, E Vellenga, W van Putten, HC Schouten, C Graux, ... New England Journal of Medicine 364 (11), 1027-1036, 2011 | 506 | 2011 |
| Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009 P Ljungman, M Bregni, M Brune, J Cornelissen, T De Witte, G Dini, ... Bone marrow transplantation 45 (2), 219-234, 2010 | 504 | 2010 |
| Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia B Löwenberg, W van Putten, M Theobald, J Gmür, L Verdonck, ... New England Journal of Medicine 349 (8), 743-752, 2003 | 500 | 2003 |
| Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma K Van Besien, FR Loberiza Jr, R Bajorunaite, JO Armitage, A Bashey, ... Blood 102 (10), 3521-3529, 2003 | 442 | 2003 |
| Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma LF Verdonck, WLJ van Putten, A Hagenbeek, HC Schouten, P Sonneveld, ... New England Journal of Medicine 332 (16), 1045-1051, 1995 | 370 | 1995 |
| Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy. P Sonneveld, M de Ridder, H van der Lelie, K Nieuwenhuis, H Schouten, ... Journal of clinical oncology 13 (10), 2530-2539, 1995 | 367 | 1995 |
| High prevalence of pain in patients with cancer in a large population-based study in The Netherlands MHJ van den Beuken-van, JM de Rijke, AG Kessels, HC Schouten, ... Pain 132 (3), 312-320, 2007 | 342 | 2007 |
| Outcome of transplantation for myelofibrosis KK Ballen, S Shrestha, KA Sobocinski, MJ Zhang, A Bashey, BJ Bolwell, ... Biology of Blood and Marrow Transplantation 16 (3), 358-367, 2010 | 341 | 2010 |
| Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up P Moreau, J San Miguel, H Ludwig, H Schouten, M Mohty, M Dimopoulos, ... Annals of Oncology 24, vi133-vi137, 2013 | 324 | 2013 |
| Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe P Ljungman, A Urbano-Ispizua, M Cavazzana-Calvo, T Demirer, G Dini, ... Bone marrow transplantation 37 (5), 439-449, 2006 | 314 | 2006 |
| Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2 … CN Harrison, N Schaap, AM Vannucchi, JJ Kiladjian, RV Tiu, P Zachee, ... The Lancet Haematology 4 (7), e317-e324, 2017 | 304 | 2017 |
| Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III … B Löwenberg, S Suciu, E Archimbaud, G Ossenkoppele, GE Verhoef, ... Blood 90 (8), 2952-2961, 1997 | 275* | 1997 |
| Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation … RJW Van Kampen, C Canals, HC Schouten, A Nagler, KJ Thomson, ... Journal of clinical oncology 29 (10), 1342-1348, 2011 | 263 | 2011 |
| Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma SM Smith, LJ Burns, K van Besien, J LeRademacher, W He, TS Fenske, ... Journal of clinical oncology 31 (25), 3100-3109, 2013 | 262 | 2013 |
Jakob Passwegbasel university在 usb.ch 的电子邮件经过验证
